Decoy Therapeutics Inc Revenue per Employee (DCOY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Decoy Therapeutics Inc   (DCOY)
 

Decoy Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Decoy Therapeutics Inc 's Revenue per employee grew on a trailing twelve month basis to $ 48,642, above the company average.
Within the Healthcare sector Decoy Therapeutics Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Decoy Therapeutics Inc has 11 employees.


What is Sales per Employee Ratio?







DCOY Revenue per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 48,642 20,694 - - -
DCOY's Total Ranking # # # # #
Seq. Revenue Change 35.06 % - - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 488,118 $ 186,856 $ 15,617
(Mar 31 2021)   (Mar 31 2016)



Financial Statements
Decoy Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit DCOY's Income Statement
Decoy Therapeutics Inc 's Revenues TTM $ 1 Millions Visit DCOY's aggregate revenue growth
What are DCOY's Sales? Visit DCOY's Sales by Segment




Other Ratios
Decoy Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
DCOY's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for DCOY's Competitors
Revenue per Employee for DCOY's Suppliers
Revenue per Employee for DCOY's Customers

You may also want to know
DCOY's Sales Growth Rates DCOY's Pe Price to earnings ratio DCOY's Receivables Turnover Ratio DCOY's Stock Quote
DCOY's Net Income Growth Rates DCOY's Ps Price to Sales ratio DCOY's Sales per Employee DCOY's Asset Turnover Ratio
DCOY's Net Margin DCOY's Pb Price to Book ratio DCOY's Financial Strength Ratios DCOY's Dividend Payout Ratio
Date modified: 2026-11-13T21:15:05+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Teleflex Incorporated  82,817.74 $ 1,283.675  Million 15,500 
Lenz Therapeutics Inc   81,309.21 $ 12.359  Million 152 
Atrium Therapeutics Inc   75,968.69 $ 38.820  Million 511 
Lucid Diagnostics Inc   66,304.88 $ 5.437  Million 82 
Metagenomi Therapeutics Inc   59,546.22 $ 7.086  Million 119 
Healthcare Services Group Inc   52,218.33 $ 1,879.860  Million 36,000 
Prime Medicine Inc   48,363.01 $ 7.061  Million 146 
Volitionrx Limited  45,928.57 $ 3.445  Million 75 
Vivos Inc  45,799.50 $ 0.092  Million 2 
Upstream Bio Inc   38,266.67 $ 2.870  Million 75 
Nexalin Technology Inc   34,663.37 $ 0.277  Million 8 
Alumis inc   32,316.96 $ 7.239  Million 224 
Longeveron Inc   30,657.89 $ 1.165  Million 38 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.